We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CFG:NYSECitizens Financial Group, Inc. Analysis

Data as of 2026-09-02 - not real-time

$68.16

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Citizens Financial Group, Inc. is priced at $68.16 and its moving averages line up in bullish order, the shorter sitting above the longer. It has lost 5.3% over the past 30 days. Relative strength is 34.7 — approaching oversold — and the MACD signal is bearish. Watch $67.67 as support and $75.33 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 15.0 sits below the sector average of 16.7. The average analyst target implies 18.6% above today's level. Revenue is growing at 14.7% on a 26.1% profit margin. The 2.67% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 19.8%, a beta of 0.95 and a maximum drawdown of 18.3%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top Market Events

Regional banking company Citizens Financial Group NYSE:CFG reported Q2 CY2026 results , with sales up 12.Updated Aug 3, 2026 0 PROVIDENCE, R.I.-- BUSINESS WIRE --Aug 3, 2026-- Citizens Financial Group, Inc. NYSE: CFG...Yahoo Finance1monCitizens Financial Group CFG Beat Q2 Earnings And Reaffirmed Guidance, Is It Fully Valued?

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 63.71
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 15.0 versus sector average of 16.7
  • Trading above the 200-day average of 63.71

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 15.0 versus sector average of 16.7
  • Analyst targets imply +18.6% versus the current price
  • Profit margin of 26.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth14.70%
Profit Margin26.05%
P/E Ratio15.0
ROE8.27%
ROA0.94%
P/B Ratio1.2
Op. Cash Flow$2.5B
Industry P/E16.7

Technical Analysis

TrendBullish
RSI34.7
Support$67.67
Resistance$75.33
MA 20$71.63
MA 50$71.43
MA 200$63.71
MACDBearish
VolumeStable
Fear & Greed Index92.25

Valuation

Fair Value$91.15
Target Price$80.82
Upside/Downside18.58%
GradeUndervalued
TypeBlend
Dividend Yield2.67%

Risk Assessment

Beta0.95
Volatility19.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.